Understanding the Physiological Role of Ligand Bias Signalling at the Glucagon-Like Peptide-1 Receptor

  • Sexton, Patrick (Primary Chief Investigator (PCI))
  • Christopoulos, Arthur (Chief Investigator (CI))
  • Dodson Michael, Mervyn (Chief Investigator (CI))
  • Sloop, Kylie (Chief Investigator (CI))
  • Willard, Francis (Chief Investigator (CI))
  • Wootten, Denise (Chief Investigator (CI))

Project: Research

Project Details

StatusFinished
Effective start/end date11/12/13 → 10/12/15

Funding

  • Eli Lilly Australia Pty Ltd: A$146,797.00
  • Eli Lilly Australia Pty Ltd: A$146,797.00